AU2008904178A0 - Anti-IL-12/23 Antibodies - Google Patents

Anti-IL-12/23 Antibodies

Info

Publication number
AU2008904178A0
AU2008904178A0 AU2008904178A AU2008904178A AU2008904178A0 AU 2008904178 A0 AU2008904178 A0 AU 2008904178A0 AU 2008904178 A AU2008904178 A AU 2008904178A AU 2008904178 A AU2008904178 A AU 2008904178A AU 2008904178 A0 AU2008904178 A0 AU 2008904178A0
Authority
AU
Australia
Prior art keywords
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2008904178A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceuticals Australia Pty Ltd
Original Assignee
Arana Therapeutics Ltd
Filing date
Publication date
Application filed by Arana Therapeutics Ltd filed Critical Arana Therapeutics Ltd
Publication of AU2008904178A0 publication Critical patent/AU2008904178A0/en
Priority to TW098127368A priority Critical patent/TWI501776B/en
Priority to BRPI0917668A priority patent/BRPI0917668A2/en
Priority to CA2733642A priority patent/CA2733642A1/en
Priority to JP2011522351A priority patent/JP5623401B2/en
Priority to ARP090103147A priority patent/AR073060A1/en
Priority to NZ590816A priority patent/NZ590816A/en
Priority to US13/058,914 priority patent/US8563697B2/en
Priority to UAA201102878A priority patent/UA104297C2/en
Priority to KR1020167026890A priority patent/KR20160116056A/en
Priority to MX2011001409A priority patent/MX2011001409A/en
Priority to PCT/AU2009/001047 priority patent/WO2010017598A1/en
Priority to KR1020117005918A priority patent/KR101781965B1/en
Priority to CN200980140286.0A priority patent/CN102177178B/en
Priority to MYPI20110625 priority patent/MY153074A/en
Priority to EA201170323A priority patent/EA026110B1/en
Priority to AU2009281713A priority patent/AU2009281713B9/en
Priority to EP09806241.7A priority patent/EP2326668B1/en
Priority to ZA2011/00711A priority patent/ZA201100711B/en
Priority to IL210903A priority patent/IL210903A/en
Priority to TN2011000052A priority patent/TN2011000052A1/en
Priority to CL2011000319A priority patent/CL2011000319A1/en
Priority to MA33692A priority patent/MA32629B1/en
Priority to US14/030,147 priority patent/US20140086922A1/en
Priority to US15/136,355 priority patent/US20160264661A1/en
Priority to IL245547A priority patent/IL245547A0/en
Abandoned legal-status Critical Current

Links

AU2008904178A 2008-08-14 2008-08-14 Anti-IL-12/23 Antibodies Abandoned AU2008904178A0 (en)

Priority Applications (25)

Application Number Priority Date Filing Date Title
EP09806241.7A EP2326668B1 (en) 2008-08-14 2009-08-14 Anti-il-12/il-23 antibodies
CN200980140286.0A CN102177178B (en) 2008-08-14 2009-08-14 Anti-IL-12/IL-23 antibodies
MYPI20110625 MY153074A (en) 2008-08-14 2009-08-14 Anti-il-12/11-23 antibodies
BRPI0917668A BRPI0917668A2 (en) 2008-08-14 2009-08-14 antibody, method for producing the antibody, nucleic acid molecule, method for treating a disease, use of an antibody, and method for producing an antigen binding domain
EA201170323A EA026110B1 (en) 2008-08-14 2009-08-14 Anti-il-12/il-23 antibodies
ARP090103147A AR073060A1 (en) 2008-08-14 2009-08-14 ANTI-BODIES ANTI-IL-12 / IL-23
NZ590816A NZ590816A (en) 2008-08-14 2009-08-14 Anti-il-12/il-23 antibodies
US13/058,914 US8563697B2 (en) 2008-08-14 2009-08-14 Anti-IL-12/IL-23 antibodies
UAA201102878A UA104297C2 (en) 2008-08-14 2009-08-14 Anti-il-12/il-23 antibody
KR1020167026890A KR20160116056A (en) 2008-08-14 2009-08-14 Anti-il-12/il-23 antibodies
MX2011001409A MX2011001409A (en) 2008-08-14 2009-08-14 Anti-il-12/il-23 antibodies.
PCT/AU2009/001047 WO2010017598A1 (en) 2008-08-14 2009-08-14 Anti-il-12/il-23 antibodies
KR1020117005918A KR101781965B1 (en) 2008-08-14 2009-08-14 Anti-il-12/il-23 antibodies
TW098127368A TWI501776B (en) 2008-08-14 2009-08-14 Anti-il-12/il-23 antibodies
CA2733642A CA2733642A1 (en) 2008-08-14 2009-08-14 Anti-il-12/il-23 antibodies
JP2011522351A JP5623401B2 (en) 2008-08-14 2009-08-14 Anti-IL-12 / IL-23 antibody
AU2009281713A AU2009281713B9 (en) 2008-08-14 2009-08-14 Anti-IL-12/IL-23 antibodies
IL210903A IL210903A (en) 2008-08-14 2011-01-27 Anti-il-12/il-23 antibodies
ZA2011/00711A ZA201100711B (en) 2008-08-14 2011-01-27 Anti-il-12/il-23 antibodies
TN2011000052A TN2011000052A1 (en) 2008-08-14 2011-01-28 Anti-il-12/il-23 antibodies
CL2011000319A CL2011000319A1 (en) 2008-08-14 2011-02-14 Antibody comprising an antigen binding domain that binds human il-12 and human il-23; nucleic acid molecule that encodes it; Method of production; and its use to treat rheumatoid arthritis, among other diseases.
MA33692A MA32629B1 (en) 2008-08-14 2011-03-11 Antibodies to EL-12
US14/030,147 US20140086922A1 (en) 2008-08-14 2013-09-18 Anti-il-12/il-23 antibodies
US15/136,355 US20160264661A1 (en) 2008-08-14 2016-04-22 Anti-il-12/il-23 antibodies
IL245547A IL245547A0 (en) 2008-08-14 2016-05-09 Anti-il-12/il-23 antibodies

Publications (1)

Publication Number Publication Date
AU2008904178A0 true AU2008904178A0 (en) 2008-09-04

Family

ID=

Similar Documents

Publication Publication Date Title
IL245547A0 (en) Anti-il-12/il-23 antibodies
IL229512A0 (en) Anti-vegf antibodies
HK1174644A1 (en) Antibody against the csf-1r csf-1r
GB0708002D0 (en) Antibodies
SI2200700T1 (en) Novel antibodies
HK1136970A1 (en) Penta-specific antibody
EP2142214A4 (en) Anti-ige antibodies
EP2138576A4 (en) Anti-claudin-4 antibody
EP2076614A4 (en) Synthetic antibodies
EP2241578A4 (en) Anti-cldn6 antibody
ZA201002275B (en) Il-23 antibodies
IL201983A (en) Anti-pan nrpa antibodies
EP2172483A4 (en) ANTI-Muc17 ANTIBODY
PL2011869T3 (en) Novel anti-cd98 antibody
GB0821100D0 (en) Antibodies
EP2337798A4 (en) Bsa-specific antibodies
GB0702888D0 (en) Novel Antibodies
GB0718737D0 (en) Antibodies
IL205073A0 (en) Anti-bst2 antibody
ZA201006099B (en) Anti-tyrp1 antibodies
ZA201007976B (en) Anti-pirb antibodies
EP2248826A4 (en) Antibody directed against pcrv
GB0818356D0 (en) Antibodies
AU2008904178A0 (en) Anti-IL-12/23 Antibodies
GB0724185D0 (en) Antibodies